Successful treatment of persistent and severe SARS‐CoV‐2 infection in a high‐risk chronic lymphocytic leukemia patient using Ronapreve™ antibodies

Patients with lymphoproliferative diseases are at an increased risk of an incomplete immune response following vaccination or SARS‐CoV‐2 infection and might develop persistent viral infection and severe COVID‐19 disease. We present a case of successful treatment of persistent and mechanical‐ventilat...

Descripción completa

Detalles Bibliográficos
Autores principales: Seganfredo, Fernanda Braga, Dias, Ana Raquel, Santos, Pedro R., Rebelo, Marta, João, Cristina, Mendes, Dina, Carmo, Eduarda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666912/
https://www.ncbi.nlm.nih.gov/pubmed/36408087
http://dx.doi.org/10.1002/ccr3.6548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666912/
https://www.ncbi.nlm.nih.gov/pubmed/36408087
http://dx.doi.org/10.1002/ccr3.6548

Ejemplares similares